Heiner Dreismann

Aug 23, 2017

Heiner Dreismann has joined Stemina Biomarker Discovery's board of directors. Dreismann is former president and CEO of Roche Molecular Systems and global head of business development for Roche Diagnostics. Stemina said that his experience will aid the company as its neurological disorders division, NeuroPointDx, prepares a metabolomics-based autism diagnostic test panel for market.